ES531072A0 - Procedimiento de preparacion de nuevas 3-hidroflavonas diversamente sustituidas sobre el oxigeno en posicion 3 - Google Patents

Procedimiento de preparacion de nuevas 3-hidroflavonas diversamente sustituidas sobre el oxigeno en posicion 3

Info

Publication number
ES531072A0
ES531072A0 ES531072A ES531072A ES531072A0 ES 531072 A0 ES531072 A0 ES 531072A0 ES 531072 A ES531072 A ES 531072A ES 531072 A ES531072 A ES 531072A ES 531072 A0 ES531072 A0 ES 531072A0
Authority
ES
Spain
Prior art keywords
hydroflavones
oxygen
procedure
preparation
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES531072A
Other languages
English (en)
Other versions
ES8504164A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cortial SA
Original Assignee
Cortial SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortial SA filed Critical Cortial SA
Publication of ES531072A0 publication Critical patent/ES531072A0/es
Publication of ES8504164A1 publication Critical patent/ES8504164A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
ES531072A 1983-04-01 1984-03-28 Procedimiento de preparacion de nuevas 3-hidroflavonas diversamente sustituidas sobre el oxigeno en posicion 3 Expired ES8504164A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8305567A FR2543550B1 (fr) 1983-04-01 1983-04-01 Nouveaux derives de la tetrahydroxy-3', 4',5,7 flavone, leur methode de preparation et leur emploi therapeutique

Publications (2)

Publication Number Publication Date
ES531072A0 true ES531072A0 (es) 1985-04-01
ES8504164A1 ES8504164A1 (es) 1985-04-01

Family

ID=9287546

Family Applications (1)

Application Number Title Priority Date Filing Date
ES531072A Expired ES8504164A1 (es) 1983-04-01 1984-03-28 Procedimiento de preparacion de nuevas 3-hidroflavonas diversamente sustituidas sobre el oxigeno en posicion 3

Country Status (11)

Country Link
US (1) US4591600A (es)
EP (1) EP0121489B1 (es)
JP (1) JPS59184173A (es)
CA (1) CA1253511A (es)
DE (1) DE3461466D1 (es)
ES (1) ES8504164A1 (es)
FR (1) FR2543550B1 (es)
MA (1) MA20086A1 (es)
OA (1) OA07695A (es)
PT (1) PT78340B (es)
ZA (1) ZA842402B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8328495D0 (en) * 1983-10-25 1983-11-23 Wellcome Found Pharmacologically active ketones
DE3505611A1 (de) * 1984-11-26 1986-05-28 Merck Patent Gmbh, 6100 Darmstadt Halogen-hydroxy-flavone
US4865599A (en) * 1986-08-18 1989-09-12 Houston Biotechnology, Inc. Ophthalmic compositions for treating nerve degeneration
GB8804016D0 (en) * 1988-02-22 1988-03-23 Boots Co Plc Therapeutic agents
IT1232343B (it) * 1989-09-28 1992-01-28 Eurogefi S P A Derivati idrosolubili di bioflavonoidi di glicosidici, procedimenti per la loro preparazione e relative composizioni farmaceutiche.
DE4011187A1 (de) * 1990-04-06 1991-10-10 Hoechst Ag Substituierte 3-thia- bzw. 3-oxa-alkyl-flavone, verfahren zu ihrer herstellung, verwendung derselben, arzneimittel auf basis dieser verbindungen sowie zwischenprodukte
US5258478A (en) * 1992-04-27 1993-11-02 Florida State University Low self-absorbing, intrinsically scintillating polymers
US5855892A (en) * 1997-09-19 1999-01-05 Potter; Susan M. Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
HK1041635A1 (zh) 1998-11-25 2002-07-19 Nutri Pharma Asa 含大豆蛋白，食用纤维及植物性雌激素混合物的成份，以及使用上述成份预防及/或治疗心血管疾病
WO2000030664A1 (en) 1998-11-25 2000-06-02 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of pulmonary diseases
US6555573B2 (en) * 2000-12-21 2003-04-29 The Quigley Corporation Method and composition for the topical treatment of diabetic neuropathy
CA2431079C (en) * 2000-12-21 2010-02-09 The Quigley Corporation Method and composition for the treatment of diabetic neuropathy
AUPR255401A0 (en) * 2001-01-16 2001-02-08 Novogen Research Pty Ltd Regulation of lipids and/or bone density and compositions therefor
WO2002087567A2 (en) * 2001-05-02 2002-11-07 Kgk Synergize Inc. Polymethoxylated flavones for treating insulin resistance
RU2182906C1 (ru) * 2001-07-13 2002-05-27 Институт химии и химической технологии СО РАН Способ получения кверцетина
RU2182907C1 (ru) * 2001-07-13 2002-05-27 Институт химии и химической технологии СО РАН Способ получения кверцетина
RU2201750C1 (ru) * 2002-03-19 2003-04-10 Закрытое акционерное общество "Медиауниверсал" Способ получения флавоноидов
US7977049B2 (en) * 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
US7083813B2 (en) * 2002-11-06 2006-08-01 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
US20050096256A1 (en) 2003-07-01 2005-05-05 President And Fellows Of Harvard College Compositions for manipulating the lifespan and stress response of cells and organisms
US20060025337A1 (en) * 2003-07-01 2006-02-02 President And Fellows Of Harvard College Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
CN101247793B (zh) * 2003-12-29 2013-04-10 哈佛大学校长及研究员协会 治疗或预防肥胖和胰岛素抗性病症的组合物
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
EP1765316A2 (en) * 2004-06-16 2007-03-28 The President and Fellows of Harvard College Methods and compositions for modulating bax-ku70-mediated apoptosis
US20060014705A1 (en) * 2004-06-30 2006-01-19 Howitz Konrad T Compositions and methods for selectively activating human sirtuins
JP2008527002A (ja) * 2005-01-13 2008-07-24 サートリス ファーマシューティカルズ， インコーポレイテッド 神経変性障害および血液凝固障害を予防および処置するための新規組成物
EP1877054A2 (en) * 2005-03-30 2008-01-16 Sirtris Pharmaceuticals, Inc. Nicotinamide riboside and analogues thereof
US20070014833A1 (en) * 2005-03-30 2007-01-18 Sirtris Pharmaceuticals, Inc. Treatment of eye disorders with sirtuin modulators
US20060292099A1 (en) * 2005-05-25 2006-12-28 Michael Milburn Treatment of eye disorders with sirtuin modulators
WO2006138418A2 (en) * 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
US20070149466A1 (en) * 2005-07-07 2007-06-28 Michael Milburn Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
US20070037193A1 (en) * 2005-08-12 2007-02-15 Rong-Hwa Lin Modulation of peroxisome proliferator-activated receptors
US7897637B2 (en) 2006-07-19 2011-03-01 The Salk Institute For Biological Studies Methods of using flavonoids to enhance memory
FR2923718B1 (fr) * 2007-11-15 2009-12-18 Caudalie Compositions de derives polyphenoliques flavonoidiques et leurs applications pour lutter contre les pathologies et le vieillissement des organismes vivants
WO2013149258A2 (en) 2012-03-30 2013-10-03 Charles Drew University of Medicine and Science Compositions and methods for treating or preventing metabolic syndrome disorders
US9132117B2 (en) 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA520376A (en) * 1956-01-03 F. Kurth Ervin Extraction of valuable products from bark
US2892845A (en) * 1957-11-26 1959-06-30 Jurd Leonard Selective etherification of the 7-hydroxyl group in polyhydroxy flavonoids
US2892846A (en) * 1958-01-14 1959-06-30 Jurd Leonard Preparation of 7-benzyl ethers of flavonoid compounds
CH473114A (de) * 1963-08-28 1969-05-31 Merck Ag E Verfahren zur Herstellung von substituierten Flavanoiden
US3661890A (en) * 1970-03-10 1972-05-09 Us Agriculture Preparation of quercetin derivatives
NZ193316A (en) * 1979-04-10 1984-07-31 Hoffmann La Roche 3-alkoxyflavone derivatives and pharmaceutical compositions
US4532254A (en) * 1983-03-17 1985-07-30 Kaken Pharmaceutical Co., Ltd. Inhibitor of aldose reductase

Also Published As

Publication number Publication date
EP0121489B1 (fr) 1986-11-26
FR2543550A1 (fr) 1984-10-05
ZA842402B (en) 1984-11-28
JPS59184173A (ja) 1984-10-19
CA1253511A (en) 1989-05-02
MA20086A1 (fr) 1984-12-31
PT78340A (fr) 1984-04-01
EP0121489A1 (fr) 1984-10-10
OA07695A (fr) 1985-05-23
FR2543550B1 (fr) 1985-08-09
PT78340B (fr) 1986-04-30
US4591600A (en) 1986-05-27
ES8504164A1 (es) 1985-04-01
DE3461466D1 (en) 1987-01-15

Similar Documents

Publication Publication Date Title
BR8806982A (pt) Composicao estabilizada
BR8802017A (pt) Composicao estabilizada
IT8648450A0 (it) Composizione orale antitartaro
IT8648451A0 (it) Composizione orale antitartaro
MX164791B (es) Composicion antimicrobiana
MX163529B (es) Composicion quimicoluminiscente
KR890700313A (ko) 살균 조성물
BR8700056A (pt) Composicao organopolisiloxano
FR2592763B1 (fr) Composition antiseptique
FI873087A0 (fi) Desensiterande dentalkomposition.
FR2583763B1 (fr) Composition d'essence
KR890701010A (ko) 식물-보호용 조성물
BR8906787A (pt) Composicao
DK49488A (da) Anaestesi-praeparat
RO94053A (ro) Compozitie fungicida sinergetica
IT1217446B (it) Composizione oftalmologica
MX163573B (es) Composicion bactericida
BR8704087A (pt) Composicao
DK119590A (da) Renin-inhiberende paptider
BR8805753A (pt) Composicao
BR8902491A (pt) Composicao
BR8907528A (pt) Composicao crio-protetora
TR26099A (tr) Islah edilmis pestisid terkip
MD74B1 (ro) Compozitie fungicida
RO95836A (ro) Compozitie erbicida lichida

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401